| Anders M Greve Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE studyAnders M Greve Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark Am J Hypertens 25:1017-23. 2012 Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) StudyAnders M Greve Department of Medicine B, The Heart Center, Rigshospitalet, 9 Blegdamsvej, Copenhagen, Denmark J Am Coll Cardiol 59:1142-9. 2012 Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)Anders M Greve Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark Am J Cardiol 108:541-7. 2011 Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis studyAnders M Greve Rigshospitalet, Department of Medicine B2142, The Heart Center, 9 Blegdamsvej, DK 2100, Copenhagen, Denmark Circulation 125:346-53. 2012 Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) studyCasper N Bang Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark Am Heart J 163:690-6. 2012 Does lowering cholesterol have an impact on the progression of aortic stenosis?Anders M Greve Department of Medicine B, Rigshospitalet, The Heart Center, Copenhagen, Denmark Ther Adv Cardiovasc Dis 2:277-86. 2008
| |